Startup Directory
70m Valuation-backed Startups in India - 2026
Last updated: · 2+ companies
70m Valuation-backed startups attract attention because investor clustering often reveals a recognizable company-building pattern. This page helps readers compare startups associated with 70m Valuation through company listings, founder profiles, and related news context. 70m Valuation typically backs companies around a recognizable investment thesis. In 2026, investor pages are useful for founders benchmarking fundraising narratives, buyers scanning validated vendors, and investors monitoring portfolio patterns. Use this directory to move from investor-led discovery to actual startup diligence with fewer steps.
RTROME Therapeutics
ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome. Biotech Healthcare Pharmaceuticals
Last round: Series B Andreessen Horowitz, $50M Series B in 2021, $70M valuation
EEduvanz
Eduvanz is a fintech Non-banking Finance Company for students seeking financial assistance. FinTech Lending EdTech
Last round: Series B Sequoia, $14M Series B in 2020, $70M valuation
Related Startup Pages
Connected Pillar Routes
Continue discovery through country, industry, stage, funding, and newsroom hubs.
Explore $70M valuation-backed Startups By Industry and Location
Frequently Asked Questions
Practical questions readers ask before comparing companies, founders, and market momentum.
What does it mean when a startup is on the 70m Valuation-backed page?
It means the directory maps the company to 70m Valuation through visible investor or funding context.
Why track 70m Valuation-backed startups separately?
Because investor-led clustering helps explain portfolio patterns and market conviction.
How should founders use this page?
Founders can benchmark positioning and fundraising narratives by studying which kinds of companies 70m Valuation supports.
Does investor backing guarantee startup quality?
No. It is a useful signal, but execution and market fit still matter more.
What should I check next?
Move from investor association into company pages, founder profiles, and news coverage for actual diligence.